Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
24.04B | 25.01B | 23.35B | 20.14B | 19.15B | 44.63B | Gross Profit |
6.07B | 6.23B | 5.32B | 4.90B | 4.66B | 240.00M | EBIT |
962.00M | 1.07B | 509.00M | 95.00M | 222.00M | -5.27B | EBITDA |
2.00B | 2.07B | 1.69B | 1.38B | 1.12B | -1.37B | Net Income Common Stockholders |
1.04B | 1.18B | 459.00M | 425.00M | 434.00M | -3.69B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.37B | 2.02B | 1.63B | 1.39B | 3.44B | 5.61B | Total Assets |
30.75B | 27.68B | 27.25B | 25.70B | 25.43B | 26.40B | Total Debt |
11.37B | 8.09B | 8.10B | 8.50B | 8.92B | 10.04B | Net Debt |
7.00B | 6.08B | 6.53B | 7.12B | 5.49B | 4.43B | Total Liabilities |
21.59B | 17.50B | 18.29B | 17.69B | 17.56B | 19.30B | Stockholders Equity |
9.17B | 10.17B | 8.96B | 8.01B | 7.87B | 7.10B |
Cash Flow | Free Cash Flow | ||||
0.00 | 931.00M | 711.00M | -1.66B | -895.00M | -3.79B | Operating Cash Flow |
0.00 | 1.50B | 1.61B | -534.00M | 284.00M | -2.68B | Investing Cash Flow |
0.00 | -817.00M | -804.00M | -933.00M | -1.19B | -4.12B | Financing Cash Flow |
0.00 | -337.00M | -583.00M | -597.00M | -1.21B | -2.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | €189.99B | 7.24 | 28.05% | 1.09% | 17.94% | 31.45% | |
78 Outperform | ¥9.45B | 7.84 | 2.69% | 7.08% | 165.76% | ||
74 Outperform | $251.43B | 6.47 | 24.36% | 0.80% | 4.38% | 54.63% | |
70 Neutral | ¥9.43B | 9.27 | 0.72% | -3.74% | -55.02% | ||
70 Neutral | ¥2.46B | 65.36 | 1.61% | -1.11% | 2.08% | ||
66 Neutral | $4.49B | 12.22 | 5.40% | 3.71% | 4.17% | -11.97% | |
62 Neutral | ¥9.93B | 18.50 | 2.28% | 15.54% | -47.78% |